{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "13e91211-707e-44ea-9adc-7e23a8fc93fc", "code": "L04AX02", "comments": "ATC|ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|IMMUNOSUPPRESSANTS|IMMUNOSUPPRESSANTS|Other immunosuppressants|thalidomide", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=L04AX02&showdescription=yes", "code_system": "WHO-ATC", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "3ae60040-999f-4b7b-a285-ae4965bb0c87", "code": "N0000008663", "comments": "Physiological Effects [PE]|Generalized Systemic Effects [PE]|Immunologic Activity Alteration [PE]|Immunologically Active Molecule Activity Alteration [PE]|Decreased Immunologically Active Molecule Activity [PE]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000008663", "code_system": "NDF-RT", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "59eb2023-fe07-4d15-b609-ce642d361eec", "code": "N0000008663", "comments": "Physiological Effects [PE]|Generalized Systemic Effects [PE]|Immunologic Activity Alteration [PE]|Decreased Immunologic Activity [PE]|Decreased Immunologically Active Molecule Activity [PE]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000008663", "code_system": "NDF-RT", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "51ba349c-42ae-422e-ab14-5d2014f1f793", "code": "QL04AX02", "comments": "VATC|IMMUNOSUPPRESSANTS|IMMUNOSUPPRESSANTS|Other immunosuppressants|thalidomide", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QL04AX02&showdescription=yes", "code_system": "WHO-VATC", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "1929ce0a-b747-481a-93d0-cf820cf1a87e", "code": "50-35-1", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=50-35-1", "code_system": "CAS", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26", "f6225041-2a1e-465b-b750-af12db593c1b" ] }, { "uuid": "aeb2c051-fa39-48ee-9954-a322cae036d6", "code": "C870", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C870", "code_system": "NCI_THESAURUS", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "fc9956e8-14eb-4b41-80ac-ea9da685ff66", "code": "NBK548371", "comments": "LiverTox|Antineoplastic|Solid tumors|Immunomodulatory", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/NBK548371/", "code_system": "LIVERTOX", "references": [ "140778f9-4d91-2167-6ea6-fc547e528656" ] }, { "uuid": "6d86cb71-f081-4399-8893-071a3869298d", "code": "D013792", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/68013792", "code_system": "MESH", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "9c4ba281-af4d-4759-a87d-8ebca0d467a8", "code": "THALIDOMIDE", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Thalidomide", "code_system": "WIKIPEDIA", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "a31795ee-163c-437c-b6cf-3e71bc8f907b", "code": "SUB10958MIG", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "cbbfd600-b984-4936-9357-f7477d84dd70", "code": "762", "type": "PRIMARY", "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=762", "code_system": "INN", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "f3544f08-fa26-428c-a2c1-359e964c8d80", "code": "THALIDOMIDE CELGENE (AUTHORIZED: MUTIPLE MYELOMA)", "comments": "EMA EPAR|DISEASES|BLOOD AND LYMPHATIC DISEASES|HEMATOLOGIC DISEASES|HEMORRHAGIC DISORDERS|HEMOSTATIC DISORDERS|MULTPLE MYELOMA", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000823/human_med_001090.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "c95db975-feb9-4dee-bb12-e6f1f9580838", "code": "200-031-1", "type": "PRIMARY", "url": "https://echa.europa.eu/substance-information/-/substanceinfo/100.000.029", "code_system": "ECHA (EC/EINECS)", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "87622425-100b-49dc-a2ce-54e3c85c5f12", "code": "7327", "type": "PRIMARY", "url": "http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7327", "code_system": "IUPHAR", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "3d59ba18-8614-4651-9a30-6e38765e8e1a", "code": "10432", "comments": "RxNorm", "type": "PRIMARY", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/10432/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "e0ed7459-81c9-4e30-9c37-d3c846dc650e", "code": "m10673", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m10673?q=authorize", "code_system": "MERCK INDEX", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "79ca4582-f689-4ade-9e66-8de4ef4d8e03", "code": "DB01041", "type": "PRIMARY", "url": "http://www.drugbank.ca/drugs/DB01041", "code_system": "DRUG BANK", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "886c2b9f-7d49-48a7-924a-c33aa1ffb604", "code": "CHEMBL468", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL468", "code_system": "ChEMBL", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "70f7edab-c1c3-4206-8142-153206d3b405", "code": "5426", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5426", "code_system": "PUBCHEM", "references": [ "4f1461fb-19ac-48ff-80c0-2c1798bdfb26" ] }, { "uuid": "f8d744a2-cc0a-1d7d-192a-3e888c9293a3", "code": "3586", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3586", "code_system": "HSDB", "references": [ "4f0df972-8b03-f313-7161-9538344ac948" ] }, { "uuid": "4eccbe01-4867-0e6e-1344-c4d4585cf245", "code": "DTXSID9022524", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID9022524", "code_system": "EPA CompTox", "references": [ "a4d12aef-7f13-c0b2-e71c-bcbf4a2506b3" ] }, { "uuid": "e8c9164b-a323-eead-8834-9aba6f13c978", "code": "32188", "comments": "ORPHAN DRUG|Designated|Treatment and maintenance of reactional lepromatous leprosy.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=32188", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "024806ef-6877-cde9-3fce-f35f33b35652", "code": "43890", "comments": "ORPHAN DRUG|Designated|Prevention of graft versus host disease.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=43890", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "22a455f3-bd79-1853-4d88-b12082c0889c", "code": "43790", "comments": "ORPHAN DRUG|Designated|Treatment of graft versus host disease.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=43790", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "0a61faf1-b5c4-6772-ad67-17c5808be75f", "code": "30788", "comments": "ORPHAN DRUG|Designated|1. Treatment of graft versus host disease in patients receiving bone marrow transplantation 2. Prevention of graft versus host disease in patients receiving bone marrow transplantation", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=30788", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "c4d88460-ea9b-bcfa-fc93-89a90765aa12", "code": "121898", "comments": "ORPHAN DRUG|Designated|Treatment of Crohn's disease.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=121898", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "78f607b0-3a6a-ba10-ec33-0622e6cab30e", "code": "72092", "comments": "ORPHAN DRUG|Designated|Treatment of the clinical manifestations of mycobacterial infection caused by Mycobacterium tuberculosis and non-tuberculous mycobacteria.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=72092", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "f73df1f5-12c0-6aed-ce26-ea008d4a575e", "code": "82594", "comments": "ORPHAN DRUG|Designated|Treatment and prevention of recurrent aphthous ulcers in severely, terminally immunocompromised patients.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=82594", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "777f87f7-af7e-b8ae-755e-6757ec5f8419", "code": "110197", "comments": "ORPHAN DRUG|Designated|Treatment of primary brain malignancies.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=110197", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "d5e73eb1-3ce2-8af6-00b2-f9e0fb8b24ec", "code": "187204", "comments": "ORPHAN DRUG|Designated|Treatment of myelodysplastic syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=187204", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "9c683487-7fce-0713-651d-e28998508371", "code": "114998", "comments": "ORPHAN DRUG|Designated|Treatment of Kaposi's sarcoma.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=114998", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "1a2c50de-a6d9-bf1c-4f8f-03d29ce222e4", "code": "115598", "comments": "ORPHAN DRUG|Designated/Approved|Treatment of multiple myeloma", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=115598", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "d6e4e145-8f41-2b8c-b2ae-c60ade9c531b", "code": "94995", "comments": "ORPHAN DRUG|Designated|Treatment of HIV-associated wasting syndrome.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=94995", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "a0930d9b-901d-2160-1a73-0798f0b11bdf", "code": "C1742", "comments": "Pharmacologic Substance[C1909]|Antineoplastic Agent[C274]|Angiogenesis Inhibitor", "codeText": "Pharmacologic Substance[C1909]|Antineoplastic Agent[C274]|Angiogenesis Inhibitor", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1742", "code_system": "NCI_THESAURUS", "references": [ "140778f9-4d91-2167-6ea6-fc547e528656" ] }, { "uuid": "08834e44-e4e4-ea0f-7315-548ac31aa8ef", "code": "80194", "comments": "ORPHAN DRUG|Designated|Treatment of severe recurrent aphthous stomatitis in severely, terminally immunocompromised patients.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=80194", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "55939802-ba50-5aa2-e66e-f779914dd503", "code": "90795", "comments": "ORPHAN DRUG|Designated/Approved|Treatment of erythema nodosum leprosum.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=90795", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "69cd91bd-e1db-8c0a-eddd-e7f6850f3cb0", "code": "585417", "comments": "ORPHAN DRUG|Designated|Treatment of hereditary hemorrhagic telangiectasia", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=585417", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "e3f8e8fb-da82-f941-84bd-b6cdc85dcd60", "code": "C574", "comments": "Pharmacologic Substance[C1909]|Immunotherapeutic Agent[C308]|Immunosuppressant", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C574", "code_system": "NCI_THESAURUS", "references": [ "140778f9-4d91-2167-6ea6-fc547e528656" ] }, { "uuid": "f73cfcb8-f088-4f76-b532-e9db36500fd0", "code": "C54677", "comments": "Drug or Chemical by Structure[C1913]|Organic Chemical[C718]|Ring Compound[C1933]|Aromatic Compounds[C1915]|Indole Compound", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C54677", "code_system": "NCI_THESAURUS", "references": [ "140778f9-4d91-2167-6ea6-fc547e528656" ] }, { "uuid": "91d5d036-5747-672b-230e-4b412353ef27", "code": "C129820", "comments": "Pharmacologic Substance[C1909]|Immunotherapeutic Agent[C308]|Antineoplastic Immunomodulating Agent", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C129820", "code_system": "NCI_THESAURUS", "references": [ "140778f9-4d91-2167-6ea6-fc547e528656" ] }, { "uuid": "5812bace-a050-ecd6-9e6e-571844143097", "code": "EU/3/01/067", "comments": "EU ORPHAN DRUG|Withdrawn|Treatment of multiple myeloma", "type": "PRIMARY", "url": "https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu301067", "code_system": "EU-Orphan Drug", "references": [ "140778f9-4d91-2167-6ea6-fc547e528656" ] }, { "uuid": "589aa0ea-f70c-449e-957c-942ff71f9d75", "code": "4Z8R6ORS6L", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "51654b85-cdab-6ae8-8331-0ea0fb21b9b6", "code": "1652500", "type": "PRIMARY", "url": "https://store.usp.org/product/1652500", "code_system": "RS_ITEM_NUM", "references": [ "140778f9-4d91-2167-6ea6-fc547e528656" ] }, { "uuid": "d70c3ee3-0d6f-cb4d-9782-4897bd529996", "code": "2616", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/2616", "code_system": "DRUG CENTRAL", "references": [ "140778f9-4d91-2167-6ea6-fc547e528656" ] }, { "uuid": "a879723d-365f-fdef-050a-37f9d31a1ebc", "code": "9513", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:9513", "code_system": "CHEBI", "references": [ "140778f9-4d91-2167-6ea6-fc547e528656" ] }, { "uuid": "68fb00db-cd81-5e74-dc55-9e77cfd351d3", "code": "74947", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:74947", "code_system": "CHEBI", "references": [ "140778f9-4d91-2167-6ea6-fc547e528656" ] }, { "uuid": "754e7b00-40b9-8cdd-3d1c-123b0012c348", "code": "66847", "type": "PRIMARY", "url": "https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=66847", "code_system": "NSC", "references": [ "67bed94c-439a-e9f5-52be-31310299415b" ] }, { "uuid": "4bfeafc7-d6ab-1c40-2f63-b287d81ab3ac", "code": "4Z8R6ORS6L", "type": "PRIMARY", "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=4Z8R6ORS6L", "code_system": "DAILYMED", "references": [ "7debd42c-fc23-2ee9-8e86-d81a179e352b" ] }, { "uuid": "50ee6076-3ee6-5215-0d37-e76b757b098e", "code": "100000089194", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "f3a087e4-3cc0-6b11-70bb-8d7ba468c65e" ] }, { "uuid": "29088b41-fc3c-675f-f4ff-329904918564", "code": "527179", "type": "PRIMARY", "url": "https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=527179", "code_system": "NSC", "references": [ "67bed94c-439a-e9f5-52be-31310299415b" ] } ], "relationships": [ { "uuid": "8795cc0b-eb03-492c-b7c2-ec7644b845c6", "amount": { "uuid": "3bba2aac-933b-44ba-a775-e593026b2350" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "2e795f4c-2b97-4ccc-a6b7-887a364015fe", "refuuid": "7629a702-22a8-4226-bd71-254d51d7cb0d", "name": "THALIDOMIDE", "unii": "4Z8R6ORS6L", "linking_id": "4Z8R6ORS6L", "ref_pname": "THALIDOMIDE", "substance_class": "reference" } }, { "uuid": "30538ecf-0351-4a38-90a2-011cb4d49e9c", "amount": { "uuid": "e7b9c587-5155-4d94-9f11-3f1bc53640b6" }, "type": "METABOLITE->PARENT", "references": [ "c21ef4d6-f498-432e-ab48-2333fb2861f0" ], "related_substance": { "uuid": "a961438f-3e93-4d3c-b9a0-060ffee291f1", "refuuid": "21ebd4f7-05e8-4cfb-b0a8-cf46925a3683", "name": "5-HYDROXYTHALIDOMIDE", "unii": "29V976C3CJ", "linking_id": "29V976C3CJ", "ref_pname": "5-HYDROXYTHALIDOMIDE", "substance_class": "reference" } }, { "uuid": "738a130c-b93b-4842-a2cf-3ddc1315c2e7", "amount": { "uuid": "269e23f8-f654-49eb-994d-4a33dd3ce6fa" }, "type": "METABOLITE->PARENT", "references": [ "c21ef4d6-f498-432e-ab48-2333fb2861f0" ], "related_substance": { "uuid": "7e6e7671-4733-487f-b17b-ce8bc064d277", "refuuid": "4c5655ef-83ff-4e2f-9555-6a49c62bff17", "name": "1'-HYDROXY THALIDOMIDE", "unii": "S99D86TD4B", "linking_id": "S99D86TD4B", "ref_pname": "1'-HYDROXY THALIDOMIDE", "substance_class": "reference" } }, { "uuid": "fbd59272-d671-48b9-acd0-74623ad5dc2a", "amount": { "uuid": "2a5d57e5-1f13-44a3-8c9e-8a905f5c7d39" }, "type": "METABOLITE->PARENT", "references": [ "c21ef4d6-f498-432e-ab48-2333fb2861f0" ], "related_substance": { "uuid": "0833b4d6-0acf-46d9-82b8-2e169d6ff079", "refuuid": "ca3f1bd1-d08d-44ee-8391-7307f4c8649c", "name": "4,1'-DIHYDROXY THALIDOMIDE", "unii": "X23VO4W70S", "linking_id": "X23VO4W70S", "ref_pname": "4,1'-DIHYDROXY THALIDOMIDE", "substance_class": "reference" } }, { "uuid": "c4d768ae-e7ae-4d2c-8bb1-ec0240bcda7f", "amount": { "uuid": "bd09a9a7-a790-493a-a482-3cb6504e32a7" }, "type": "METABOLITE->PARENT", "references": [ "c21ef4d6-f498-432e-ab48-2333fb2861f0" ], "related_substance": { "uuid": "78a86b64-bc06-4616-a6b2-e494ba2d0016", "refuuid": "7f993ad1-d012-4de3-aa89-5c38be952177", "name": "5,1'-DIHYDROXY THALIDOMIDE", "unii": "FV3ZQQ199B", "linking_id": "FV3ZQQ199B", "ref_pname": "5,1'-DIHYDROXY THALIDOMIDE", "substance_class": "reference" } }, { "uuid": "c9f05006-8390-4c2f-91f8-fd63f0c98822", "amount": { "uuid": "7860a3aa-0db9-45ae-b028-0e8fdf30dd0f" }, "type": "METABOLITE->PARENT", "references": [ "c21ef4d6-f498-432e-ab48-2333fb2861f0" ], "related_substance": { "uuid": "2fe0f452-bc70-4b42-8345-2ce66b3b941f", "refuuid": "0fadc3d8-1dc7-4ba5-9d9c-3f66b25a63ce", "name": "N-PHTHALOYL-DL-GLUTAMIC ACID", "unii": "C5DK277925", "linking_id": "C5DK277925", "ref_pname": "N-PHTHALOYL-DL-GLUTAMIC ACID", "substance_class": "reference" } }, { "uuid": "2569d3b2-e84f-46a1-828d-4baafaeb31ef", "amount": { "uuid": "ca900e78-c644-4885-a366-c86c53d57445" }, "type": "METABOLITE->PARENT", "references": [ "c21ef4d6-f498-432e-ab48-2333fb2861f0" ], "related_substance": { "uuid": "e23ae352-760b-4f52-8e63-307afeee4694", "refuuid": "635ed06d-b0c6-47be-b7c2-7e9ce03d10df", "name": "2-(3-HYDROXYPHTHALIMIDO)GLUTARIC ACID", "unii": "ZM4R50T0DR", "linking_id": "ZM4R50T0DR", "ref_pname": "2-(3-HYDROXYPHTHALIMIDO)GLUTARIC ACID", "substance_class": "reference" } }, { "uuid": "6f076e6b-10cd-4667-8b00-d7b441a4f75f", "amount": { "uuid": "f509f53c-6f9c-4895-9e8a-70b9bce15a18" }, "type": "METABOLITE->PARENT", "references": [ "c21ef4d6-f498-432e-ab48-2333fb2861f0" ], "related_substance": { "uuid": "2cdfe371-dac3-4432-b4e0-19478b1286be", "refuuid": "3901341d-d4da-46a1-ae92-bf60ebae464c", "name": "2-(4-HYDROXYPHTHALIMIDO)GLUTARIC ACID", "unii": "8X81U09Q3A", "linking_id": "8X81U09Q3A", "ref_pname": "2-(4-HYDROXYPHTHALIMIDO)GLUTARIC ACID", "substance_class": "reference" } }, { "uuid": "5c8ca783-86d4-4535-8fff-ed8078f72e8b", "amount": { "uuid": "f23b7d2f-8e37-4868-8aed-f60a3a9a2c9b" }, "type": "ENANTIOMER->RACEMATE", "related_substance": { "uuid": "ad997ec0-fe2d-46d1-a759-c15ce9928e27", "refuuid": "56e8d65d-e655-45e0-99cd-172f1084f34e", "name": "THALIDOMIDE, (R)-", "unii": "QN61H68KLK", "linking_id": "QN61H68KLK", "ref_pname": "THALIDOMIDE, (R)-", "substance_class": "reference" } }, { "uuid": "732a4b7a-901c-466b-aff6-521557e97159", "amount": { "uuid": "68dacc44-e96c-49f9-b7d4-37333f4e3104" }, "type": "ENANTIOMER->RACEMATE", "related_substance": { "uuid": "d9dbbabe-be69-4bdb-8923-7188202eb214", "refuuid": "d990eef6-e989-459a-acbc-a1da8c93152a", "name": "THALIDOMIDE, (S)-", "unii": "TG87FSR590", "linking_id": "TG87FSR590", "ref_pname": "THALIDOMIDE, (S)-", "substance_class": "reference" } }, { "uuid": "dca34c27-52a4-4023-a4b4-5916d5842689", "amount": { "uuid": "78924896-f319-4c1b-9eaf-664362976bba" }, "type": "TARGET->INHIBITOR", "interaction_type": "BINDING", "references": [ "96e5f87d-f86f-4634-9b00-472919968018" ], "related_substance": { "uuid": "1177be10-547e-4d97-9eac-5d00503a461e", "refuuid": "09e65577-6e22-4570-b37b-3991b961f90b", "name": "TUMOR NECROSIS FACTOR-.ALPHA. HUMAN (PLASMA DERIVED, SOLUBLE FORM)", "unii": "4TVX2I407K", "linking_id": "4TVX2I407K", "ref_pname": "TUMOR NECROSIS FACTOR-.ALPHA. HUMAN (PLASMA DERIVED, SOLUBLE FORM)", "substance_class": "reference" } }, { "uuid": "e9986b41-d688-4262-930d-0ea164f327ee", "amount": { "uuid": "b221dc16-9462-4265-a1a1-975359c2a48e", "average": 30, "units": "MICROMOLAR" }, "comments": "Dose-dependent interaction with the CRBN-DDB1 complex", "qualification": "IC50", "type": "TARGET->INHIBITOR", "references": [ "86fd40aa-0575-868e-56eb-ea0b19bcb485" ], "related_substance": { "uuid": "c0b1a294-2b4d-4bc7-a375-e3c2d83e807c", "refuuid": "7aeff1de-df74-40bf-ae98-386217976155", "name": "CEREBLON", "unii": "HR6E2AWX74", "linking_id": "HR6E2AWX74", "ref_pname": "CEREBLON", "substance_class": "reference" } }, { "uuid": "49a3f19e-3de6-4584-8da4-15d3b1cec393", "amount": { "uuid": "d52287a0-b9de-4a07-b776-40fd9635a0a1", "average": 8.5, "units": "NANOMOLAR" }, "qualification": "Kd", "type": "TARGET->INHIBITOR", "references": [ "49c72124-6209-7104-18a9-6c487966e941" ], "related_substance": { "uuid": "e5c55e3e-5f09-44da-aad5-b5a061387269", "refuuid": "7aeff1de-df74-40bf-ae98-386217976155", "name": "CEREBLON", "unii": "HR6E2AWX74", "linking_id": "HR6E2AWX74", "ref_pname": "CEREBLON", "substance_class": "reference" } }, { "uuid": "850eaa89-497b-47ce-922c-bfb9607ee048", "amount": { "uuid": "9c82c274-9d57-499d-a88c-0ccd26d24125" }, "comments": "CYP2C9 and CYP1A2 were also mediators in this reaction.", "type": "METABOLITE->PARENT", "mediator_substance": { "uuid": "59a90f8f-b203-4b77-a5de-9b12bba4ad13", "refuuid": "4f746c19-0e0a-447a-beda-d28b91d6f23e", "name": "CYTOCHROME P450 2C19", "unii": "081I12ZA58", "linking_id": "081I12ZA58", "ref_pname": "CYTOCHROME P450 2C19", "substance_class": "reference" }, "references": [ "88af6f3e-8020-4123-8e0d-ab01698585af" ], "related_substance": { "uuid": "95bcb295-3375-4d91-bb0f-c8e37171ac4d", "refuuid": "d93104ed-246b-445d-943b-32a111a774ca", "name": "5,6-DIHYDROXYTHALIDOMIDE", "unii": "QEA20YZ2JY", "linking_id": "QEA20YZ2JY", "ref_pname": "5,6-DIHYDROXYTHALIDOMIDE" } }, { "uuid": "2ecca7f9-c7a9-4e72-9eac-96393ebb600b", "amount": { "uuid": "b9d4453d-09b3-4f0a-99e2-9b0a770b55a4" }, "type": "SUBSTANCE->SUB_ALTERNATE", "related_substance": { "uuid": "fe652445-83fe-42b5-9022-7df20ce35eb6", "refuuid": "425846e5-c1f4-4378-9c0a-21ca564b3da0", "name": "ALTERNATIVE DEFINITION for [THALIDOMIDE]", "linking_id": "425846e5-c1f4-4378-9c0a-21ca564b3da0", "ref_pname": "NO NAME" } } ], "substance_class": "chemical", "names": [ { "uuid": "4bb40599-75cb-48d0-a546-653e640d2a13", "name": "(±)-N-(2,6-DIOXO-3-PIPERIDYL)PHTHALIMIDE", "stdName": "(+/-)-N-(2,6-DIOXO-3-PIPERIDYL)PHTHALIMIDE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "957d3b05-95e5-45d3-b327-39e98d78a747" ], "display_name": false }, { "uuid": "a75c1598-c952-4ec8-a16a-3bfc0c3fe4dc", "name": ".ALPHA.-(N-PHTHALIMIDO)GLUTARIMIDE", "stdName": ".ALPHA.-(N-PHTHALIMIDO)GLUTARIMIDE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "957d3b05-95e5-45d3-b327-39e98d78a747" ], "display_name": false }, { "uuid": "654e4db7-ebcc-43f7-8f4e-14bcb9b6a667", "name": ".ALPHA.-PHTHALIMIDOGLUTARIMIDE", "stdName": ".ALPHA.-PHTHALIMIDOGLUTARIMIDE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "81f202c5-5a99-4e46-850c-e287c0c9e8e2", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "90296ff8-3612-42da-8a47-6a89515f7ce8", "name": "1H-ISOINDOLE-1,3(2H)-DIONE, 2-(2,6-DIOXO-3-PIPERIDINYL)-, (±)-", "stdName": "1H-ISOINDOLE-1,3(2H)-DIONE, 2-(2,6-DIOXO-3-PIPERIDINYL)-, (+/-)-", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "957d3b05-95e5-45d3-b327-39e98d78a747" ], "display_name": false }, { "uuid": "2e79569f-41e2-4917-b6d4-6c35523d725e", "name": "2,6-DIOXO-3-PHTHALIMIDOPIPERIDINE", "stdName": "2,6-DIOXO-3-PHTHALIMIDOPIPERIDINE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "81f202c5-5a99-4e46-850c-e287c0c9e8e2", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "a1f3974c-8390-40f1-989c-181549347d73", "name": "2-(2,6-DIOXO-3-PIPERIDINYL)-1H-ISOINDOLE-1,3(2H)-DIONE", "stdName": "2-(2,6-DIOXO-3-PIPERIDINYL)-1H-ISOINDOLE-1,3(2H)-DIONE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "81f202c5-5a99-4e46-850c-e287c0c9e8e2", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "d495e66c-a4a4-4c2a-9b26-2601ba4a5c6b", "name": "3-PHTHALIMIDOGLUTARIMIDE", "stdName": "3-PHTHALIMIDOGLUTARIMIDE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "eaa796f8-6d0f-4c41-a9c5-52aadc873f8f", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "97a6c7c8-8c71-4a5a-b957-68e21ee1a4d0", "name": "CELGENE", "stdName": "CELGENE", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "eaa796f8-6d0f-4c41-a9c5-52aadc873f8f", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "3d8016b5-b505-4608-962f-1c6c236ad277", "name": "CONTERGAN", "stdName": "CONTERGAN", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "eaa796f8-6d0f-4c41-a9c5-52aadc873f8f", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "457251ec-ba51-4113-9112-3c6cd77750b3", "name": "DISTAVAL", "stdName": "DISTAVAL", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "eaa796f8-6d0f-4c41-a9c5-52aadc873f8f", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "03119a1d-6b5f-4570-989e-cb265186b53f", "name": "K-17", "stdName": "K-17", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "eaa796f8-6d0f-4c41-a9c5-52aadc873f8f", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "0c63ab04-b3bf-4a4c-86cf-1d706cb12e27", "name": "KEVADON", "stdName": "KEVADON", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "eaa796f8-6d0f-4c41-a9c5-52aadc873f8f", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "73c7b485-aa74-4445-b977-b5d0e4504d59", "name": "MYRIN", "stdName": "MYRIN", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "eaa796f8-6d0f-4c41-a9c5-52aadc873f8f", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "76f0f967-cff2-abab-6c65-5a2b4b8e1e0b", "name": "N-(2,6-Dioxo-3-piperidyl)phthalimide", "stdName": "N-(2,6-DIOXO-3-PIPERIDYL)PHTHALIMIDE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "c9898e87-617c-942e-2fe9-3d81d21c8e3d" ], "display_name": false }, { "uuid": "5b502f05-94b5-4339-8b74-eb2834a04663", "name": "N-PHTHALYLGLUTAMIC ACID IMIDE", "stdName": "N-PHTHALYLGLUTAMIC ACID IMIDE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "81f202c5-5a99-4e46-850c-e287c0c9e8e2", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "7f36085a-1a1e-41f5-9650-33efec994ebf", "name": "NEUROSEDYN", "stdName": "NEUROSEDYN", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "eaa796f8-6d0f-4c41-a9c5-52aadc873f8f", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "720a6e6e-a5ce-4f5b-9eec-89729cd2fafc", "name": "NSC-527179", "stdName": "NSC-527179", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "eaa796f8-6d0f-4c41-a9c5-52aadc873f8f", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "74e9c05b-41f3-4de6-b59e-08b606f36979", "name": "NSC-66847", "stdName": "NSC-66847", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "eaa796f8-6d0f-4c41-a9c5-52aadc873f8f", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "bb50a1d9-7706-4391-9f7c-101a34f84cc2", "name": "PANTOSEDIV", "stdName": "PANTOSEDIV", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "eaa796f8-6d0f-4c41-a9c5-52aadc873f8f", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "53435a02-6c35-4f2f-8770-4256eed3fc8b", "name": "PHARMION", "stdName": "PHARMION", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "eaa796f8-6d0f-4c41-a9c5-52aadc873f8f", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "a6bbf6a1-8d1c-4c0f-b6a0-58d4b4c14479", "name": "SOFTENON", "stdName": "SOFTENON", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "81f202c5-5a99-4e46-850c-e287c0c9e8e2", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "e4aa7233-d5c5-402d-b2f0-35a7e5bad9fe", "name": "THALED", "stdName": "THALED", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "bcff650e-4526-4366-8c79-0155ebab939a", "063b091c-5a77-4866-b4bf-86edd8060925" ], "display_name": false }, { "uuid": "44dff954-5333-49b2-861c-f47b8deb0f3d", "name": "THALIDOMIDE", "stdName": "THALIDOMIDE", "type": "of", "languages": [ "en" ], "preferred": false, "references": [ "673571cc-d765-433a-a978-aa0741feb994", "9607fd1e-4e08-48bd-888c-ad31a6aae202", "526fdffe-b20c-45c8-8c2d-3d36a639f9db", "8697563b-28bd-4dc7-9960-5c71b25425a2", "67e0ab4e-4c22-43e8-b594-fa6d5d431aa8", "5e48974a-fbca-49ca-8df9-0a159dead06d", "bb3b4231-e4de-4b60-976b-7304dba0dee7", "692e33a5-9e29-47e8-a376-f5b9c7e2a54e", "da093f01-d6c7-4a4a-a195-8e329274c65d", "98335ec9-842b-42a0-84bc-cdd9e2b42d69", "8053b9c7-e5ef-4a82-ad36-6109a5a9a16a", "2d9e25e7-5ec5-48dd-8778-be1a952db90f", "22d4492a-c0f4-40af-a726-a3ef9b65c0c0", "c230ebd3-6321-4a94-85ea-5c4b7d0f4dd4", "23f2cce4-5079-4f5c-8545-8341d06fd7c7", "64feb5a5-2e05-4db6-bbd1-9248f3726c75", "063b091c-5a77-4866-b4bf-86edd8060925", "957d3b05-95e5-45d3-b327-39e98d78a747", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7", "de264218-5378-46c3-8da2-7ef561af3963", "9de5e7f1-e545-4bef-bcef-dc81c8e63177", "06f81d05-a442-4da1-a8a2-5e6e75c34bd8", "a333a0d6-7c38-4b65-bd85-44eb19e4378a", "f26dbac8-1589-420e-9cb5-79567356755c", "85c25ee0-c1c9-43be-a0a3-7833fefbd828", "5f9b0aea-64b0-4e1e-83b7-f5462ca7ce32" ], "display_name": true, "domains": [ "drug" ], "name_orgs": [ { "uuid": "a91596d9-67de-4e7f-bbf0-bfe7ecd5352c", "name_org": "INN" }, { "uuid": "6731d418-7e18-4980-9e1c-beb46274bb97", "name_org": "USAN" } ] }, { "uuid": "d0e2a1e4-e9c2-4f5f-a866-87fbcca34adf", "name": "THALIDOMIDE [EMA EPAR]", "stdName": "THALIDOMIDE [EMA EPAR]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "de264218-5378-46c3-8da2-7ef561af3963", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "1c616e78-5af2-4d78-9c0d-e7634b009df4", "name": "THALIDOMIDE [HSDB]", "stdName": "THALIDOMIDE [HSDB]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "5e48974a-fbca-49ca-8df9-0a159dead06d", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "11704849-70bc-4261-bb7c-bcc7d2628b40", "name": "THALIDOMIDE [JAN]", "stdName": "THALIDOMIDE [JAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "063b091c-5a77-4866-b4bf-86edd8060925", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "2775f6bd-4f1c-46d1-89e6-775da289232d", "name": "THALIDOMIDE [MART.]", "stdName": "THALIDOMIDE [MART.]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "9de5e7f1-e545-4bef-bcef-dc81c8e63177" ], "display_name": false }, { "uuid": "ff9fba23-a64a-4d3b-9c82-402f3b32e16a", "name": "THALIDOMIDE [MI]", "stdName": "THALIDOMIDE [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c230ebd3-6321-4a94-85ea-5c4b7d0f4dd4", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "8d6fd5a6-2c4d-4d7d-90f7-80844492c83d", "name": "THALIDOMIDE [ORANGE BOOK]", "stdName": "THALIDOMIDE [ORANGE BOOK]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a333a0d6-7c38-4b65-bd85-44eb19e4378a" ], "display_name": false }, { "uuid": "54813bad-9a4c-4d65-ac78-b89a8ef06db5", "name": "THALIDOMIDE [USAN]", "stdName": "THALIDOMIDE [USAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2d9e25e7-5ec5-48dd-8778-be1a952db90f" ], "display_name": false }, { "uuid": "7bc74807-ab6f-9fab-0b5a-a233acbfd5bf", "name": "THALIDOMIDE [USP MONOGRAPH]", "stdName": "THALIDOMIDE [USP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "610b5d65-9fd8-232b-0b8c-4d9316fef0af" ], "display_name": false }, { "uuid": "7e1e8aa6-6175-4efc-862d-1c56250d80e9", "name": "THALIDOMIDE [USP-RS]", "stdName": "THALIDOMIDE [USP-RS]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f26dbac8-1589-420e-9cb5-79567356755c", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "405b24b1-1102-4892-9cf3-2f1b8fb59864", "name": "THALIDOMIDE [VANDF]", "stdName": "THALIDOMIDE [VANDF]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "673571cc-d765-433a-a978-aa0741feb994", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "a0540fe9-574b-40f5-af11-c7029daa216e", "name": "THALOMID", "stdName": "THALOMID", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "2d377ec8-2504-4d61-8df4-cabeebcece45", "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7" ], "display_name": false }, { "uuid": "244f5579-3eb0-2c90-ac07-9cac8f7199d4", "name": "Thalidomide [WHO-DD]", "stdName": "THALIDOMIDE [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "4eef6ade-95b9-2ff9-3cc2-d75540314c8a" ], "display_name": false }, { "uuid": "797506ea-8aeb-4949-be6e-77223ee1dc09", "name": "thalidomide [INN]", "stdName": "THALIDOMIDE [INN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "8697563b-28bd-4dc7-9960-5c71b25425a2" ], "display_name": false } ], "references": [ { "uuid": "957d3b05-95e5-45d3-b327-39e98d78a747", "citation": "USP Dictionary 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "eaa796f8-6d0f-4c41-a9c5-52aadc873f8f", "citation": "STN", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "27d4ea9e-5c85-454b-a5b8-00a1a58ff0c7", "citation": "STN (SCIFINDER)", "doc_type": "STN (SCIFINDER)", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "2d377ec8-2504-4d61-8df4-cabeebcece45", "citation": "USP DICTIONARY 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "8697563b-28bd-4dc7-9960-5c71b25425a2", "citation": "INN Proposed List 8", "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL08.pdf", "doc_type": "INN_LIST", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "2d9e25e7-5ec5-48dd-8778-be1a952db90f", "citation": "USP DICTIONARY 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "692e33a5-9e29-47e8-a376-f5b9c7e2a54e", "citation": "USP 33", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "063b091c-5a77-4866-b4bf-86edd8060925", "citation": "KEGG 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a333a0d6-7c38-4b65-bd85-44eb19e4378a", "citation": "ORANGE BOOK 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "9de5e7f1-e545-4bef-bcef-dc81c8e63177", "citation": "MARTINDALE 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "c230ebd3-6321-4a94-85ea-5c4b7d0f4dd4", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "bcff650e-4526-4366-8c79-0155ebab939a", "citation": "D00754", "doc_type": "KEGG", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "de264218-5378-46c3-8da2-7ef561af3963", "citation": "EMA", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "5e48974a-fbca-49ca-8df9-0a159dead06d", "citation": "HSDB", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "f26dbac8-1589-420e-9cb5-79567356755c", "citation": "USP/NF", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "81f202c5-5a99-4e46-850c-e287c0c9e8e2", "citation": "MERCK", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "526fdffe-b20c-45c8-8c2d-3d36a639f9db", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "673571cc-d765-433a-a978-aa0741feb994", "citation": "NDF-RT", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "4f1461fb-19ac-48ff-80c0-2c1798bdfb26", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493390773000, "tags": [ "NOMEN" ] }, { "uuid": "c21ef4d6-f498-432e-ab48-2333fb2861f0", "citation": "BIOL. PHARM. BULL. 25(5) 597?604 (2002)", "url": "https://www.jstage.jst.go.jp/article/bpb/25/5/25_5_597/_pdf", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "96e5f87d-f86f-4634-9b00-472919968018", "citation": "NEUROSCI BULL. 2017 APR 1. DOI: 10.1007/S12264-017-0124-3.", "url": "https://www.ncbi.nlm.nih.gov/pubmed/28365861", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "2da54bf7-3358-464d-95d0-41aa995f844c", "citation": "SRS import [4Z8R6ORS6L]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=4Z8R6ORS6L", "doc_type": "SRS", "public_domain": true, "document_date": 1493390773000, "tags": [ "NOMEN" ] }, { "uuid": "98335ec9-842b-42a0-84bc-cdd9e2b42d69", "citation": "THALIDOMIDE [INN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "22d4492a-c0f4-40af-a726-a3ef9b65c0c0", "citation": "THALIDOMIDE [USAN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "06f81d05-a442-4da1-a8a2-5e6e75c34bd8", "citation": "THALIDOMIDE [USP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "da093f01-d6c7-4a4a-a195-8e329274c65d", "citation": "THALIDOMIDE [JAN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "67e0ab4e-4c22-43e8-b594-fa6d5d431aa8", "citation": "THALIDOMIDE [ORANGE BOOK]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "9607fd1e-4e08-48bd-888c-ad31a6aae202", "citation": "THALIDOMIDE [MART.]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "23f2cce4-5079-4f5c-8545-8341d06fd7c7", "citation": "THALIDOMIDE [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "8053b9c7-e5ef-4a82-ad36-6109a5a9a16a", "citation": "THALIDOMIDE [EMA EPAR]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "5f9b0aea-64b0-4e1e-83b7-f5462ca7ce32", "citation": "THALIDOMIDE [HSDB]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "64feb5a5-2e05-4db6-bbd1-9248f3726c75", "citation": "THALIDOMIDE [USP-RS]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "bb3b4231-e4de-4b60-976b-7304dba0dee7", "citation": "THALIDOMIDE [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "85c25ee0-c1c9-43be-a0a3-7833fefbd828", "citation": "THALIDOMIDE [VANDF]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "c9898e87-617c-942e-2fe9-3d81d21c8e3d", "citation": "USP", "doc_type": "USP", "public_domain": true }, { "uuid": "4f0df972-8b03-f313-7161-9538344ac948", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+50-35-1", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "a4d12aef-7f13-c0b2-e71c-bcbf4a2506b3", "citation": "WEBSITE", "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=50-35-1", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "49c72124-6209-7104-18a9-6c487966e941", "citation": "Ito, Takumi, et al. \"Identification of a primary target of thalidomide teratogenicity.\" science 327.5971 (2010): 1345-1350.", "doc_type": "JA", "public_domain": true }, { "uuid": "86fd40aa-0575-868e-56eb-ea0b19bcb485", "citation": "Leukemia. 2012 Nov;26(11):2326-35. doi: 10.1038/leu.2012.119. Epub 2012 May 3.", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496085/", "doc_type": "JA", "public_domain": true }, { "uuid": "f3a087e4-3cc0-6b11-70bb-8d7ba468c65e", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true }, { "uuid": "140778f9-4d91-2167-6ea6-fc547e528656", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "f6225041-2a1e-465b-b750-af12db593c1b", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "88af6f3e-8020-4123-8e0d-ab01698585af", "citation": "FOYE’S PRINCIPLES OF MEDICINAL CHEMISTRY; 7th ED; LEMKE TL, ED; 2013; ISBN 978-1-60913-345-0", "url": "https://tradownload.biz/results/foye-s-principles-of-medicinal-chemistry-pdf.html", "doc_type": "BOOK", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "610b5d65-9fd8-232b-0b8c-4d9316fef0af", "citation": "USP 10/2020", "doc_type": "USPNF", "public_domain": true }, { "uuid": "67bed94c-439a-e9f5-52be-31310299415b", "citation": "NCI", "doc_type": "NCI DRUG DICTIONARY", "public_domain": true }, { "uuid": "7debd42c-fc23-2ee9-8e86-d81a179e352b", "citation": "DailyMed", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "4eef6ade-95b9-2ff9-3cc2-d75540314c8a", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "d3d599f6-4fe4-4434-ba4d-f4409bebe5f4", "id": "d3d599f6-4fe4-4434-ba4d-f4409bebe5f4", "molfile": "\n Marvin 01132110582D \n\n 19 21 0 0 0 0 999 V2000\n 3.1449 -2.5526 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.9364 -3.2772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.4348 -3.9560 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 4.2585 -3.9407 0.0000 C 0 0 0 0 0 0 0 0 0 3 0 0\n 4.6475 -3.2161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.4941 -3.2314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.9187 -3.9153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 6.7373 -3.9026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 5.5144 -4.6246 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 4.6678 -4.6195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.3119 -5.2831 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.9593 -4.6195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.2365 -5.2831 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1610 -4.3755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.4517 -4.8026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.7271 -4.3958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.7348 -3.6204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.4212 -3.1628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1610 -3.5594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 2 0 0 0 0\n 2 3 1 0 0 0 0\n 19 2 1 0 0 0 0\n 4 3 1 0 0 0 0\n 12 3 1 0 0 0 0\n 5 4 1 0 0 0 0\n 10 4 1 0 0 0 0\n 6 5 1 0 0 0 0\n 7 6 1 0 0 0 0\n 8 7 2 0 0 0 0\n 9 7 1 0 0 0 0\n 9 10 1 0 0 0 0\n 11 10 2 0 0 0 0\n 13 12 2 0 0 0 0\n 14 12 1 0 0 0 0\n 15 14 1 0 0 0 0\n 14 19 2 0 0 0 0\n 16 15 2 0 0 0 0\n 17 16 1 0 0 0 0\n 17 18 2 0 0 0 0\n 18 19 1 0 0 0 0\nM END", "smiles": "c1ccc2c(c1)C(=O)N(C3CCC(=O)NC3=O)C2=O", "formula": "C13H10N2O4", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "RACEMIC", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "45b58b08-731f-48ba-b51a-7d5769fe224d" }, "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "258.23", "optical_activity": "( + / - )", "stereo_centers": 1 } ], "definition_level": "COMPLETE", "uuid": "7629a702-22a8-4226-bd71-254d51d7cb0d", "version": "66", "structure": { "id": "39703750-7604-44cf-9e7e-ae3d1aa9cf48", "molfile": "\n Marvin 01132103032D \n\n 19 21 0 0 0 0 999 V2000\n 3.4348 -3.9560 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 2.9364 -3.2772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.9593 -4.6195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.6678 -4.6195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.5144 -4.6246 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 4.2585 -3.9407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1610 -4.3755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1610 -3.5594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.9187 -3.9153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.1449 -2.5526 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 3.2365 -5.2831 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 4.6475 -3.2161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.3119 -5.2831 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 6.7373 -3.9026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 5.4941 -3.2314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.4517 -4.8026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.4212 -3.1628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.7348 -3.6204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.7271 -4.3958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2 1 1 0 0 0 0\n 3 1 1 0 0 0 0\n 4 6 1 0 0 0 0\n 5 4 1 0 0 0 0\n 6 1 1 0 0 0 0\n 7 3 1 0 0 0 0\n 8 2 1 0 0 0 0\n 9 15 1 0 0 0 0\n 10 2 2 0 0 0 0\n 11 3 2 0 0 0 0\n 12 6 1 0 0 0 0\n 13 4 2 0 0 0 0\n 14 9 2 0 0 0 0\n 15 12 1 0 0 0 0\n 16 7 2 0 0 0 0\n 17 8 2 0 0 0 0\n 18 17 1 0 0 0 0\n 19 16 1 0 0 0 0\n 7 8 1 0 0 0 0\n 5 9 1 0 0 0 0\n 18 19 2 0 0 0 0\nM END", "smiles": "c1ccc2c(c1)C(=O)N(C3CCC(=O)NC3=O)C2=O", "formula": "C13H10N2O4", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "RACEMIC", "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "258.23", "optical_activity": "( + / - )", "references": [ "957d3b05-95e5-45d3-b327-39e98d78a747", "2da54bf7-3358-464d-95d0-41aa995f844c", "8697563b-28bd-4dc7-9960-5c71b25425a2" ], "stereo_centers": 1 }, "unii": "4Z8R6ORS6L" } ] }